Standrew S.A. (WSE:STD)

Oncternal Therapeutics Revenue

Standrew had revenue of 3.06M PLN in the quarter ending June 30, 2025, a decrease of -31.93%. This brings the company's revenue in the last twelve months to 14.36M, down -31.01% year-over-year. In the year 2024, Standrew had annual revenue of 17.75M, down -23.79%.

• Revenue (ttm): 14.36M
• Revenue Growth: -31.01%
• P/S Ratio: 1.01
• Revenue / Employee: 350.16K
• Employees: 42
• Market Cap: 14.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	17.75M	-5.54M	-23.79%
Dec 31, 2023	23.29M	2.23M	10.60%
Dec 31, 2022	21.05M	2.49M	13.38%
Dec 31, 2021	18.57M	3.22M	21.00%
Dec 31, 2020	15.35M	-5.02M	-24.64%